Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.17 (
MMP-3
)
3,419
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Stromelysins, which are the metalloproteinases with the widest substrate specificities, play a critical role in tumor invasion and metastasis. We have previously reported an element (SPRE) of the
stromelysin
promoter located between nucleotides -1221 and -1203 that is necessary and sufficient for the control of
stromelysin
gene expression by mitogenic activation, which induces a nuclear activity that binds to this sequence. Using a concatenated probe with several copies of this element to screen a lambda gt11 cDNA expression library from mouse Swiss 3T3 fibroblasts, we report here the molecular cloning of a cDNA coding for a novel protein (
SPBP
) of 937 amino acids that binds to this element and has several features of a transcription factor, such as a putative leucine zipper region, a nuclear localization signal, and a basic domain with homology to the DNA-binding domains of Fos and Jun. Evidence that
SPBP
is at least a critical component of the mitogen-induced SPRE nuclear binding activity is presented here. Furthermore, the transfection of an expression plasmid for
SPBP
transactivates reporter chloramphenicol acetyltransferase plasmids containing either the full-length
stromelysin
promoter or a single copy of the SPRE cloned upstream of the herpes simplex virus thymidine kinase minimal promoter. Therefore, the results presented here identify a novel transcription factor critically involved in the control of
stromelysin
expression.
...
PMID:Molecular characterization of a novel transcription factor that controls stromelysin expression. 776 Aug 12
Platelet-derived growth factor (PDGF) induces the expression of human
stromelysin
-1, a matrix metalloproteinase involved in tumor invasion and metastasis. Here it is shown that
stromelysin
-1 gene induction by PDGF depends on Ras and involves three previously identified promoter elements (the
stromelysin
-1 PDGF-responsive element (SPRE) site, the two head-to-head polyomavirus enhancer A-binding protein-3 (PEA3) sites, and the activator protein-1 (AP-1) binding site). During mitogenic induction, these responsive elements appear to be organized in two independent transcriptional units, SPRE-AP-1 and PEA3-AP-1, which result from specific element cross-talking. Interestingly, expression of a dominant negative mutant of Raf-1 significantly interfered with the induction through PEA3-AP-1 but not with that operating through SPRE-AP-1. Conversely, only the induction operating through SPRE-AP-1 was affected significantly by the expression of a dominant negative mutant of the atypical lambda/iota protein kinase C (lambda/iotaPKC). These data strongly suggest that the signal triggered by PDGF flows through Ras and bifurcates toward two distinct pathways, one operating through Raf and involving PEA3-AP-1 and the other one Raf-independent, operating through lambda/iotaPKC and SPRE-AP-1. Furthermore, we present evidence suggesting that the novel SPRE-binding transcription factor
SPBP
cross-couples with c-Jun to transactivate the SPRE site.
...
PMID:Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. 866 78
The activator of
stromelysin 1
gene transcription,
SPBP
, interacts with the RING finger protein RNF4. Both proteins are ubiquitously expressed and localized in the nucleus. RNF4 facilitates accumulation of specific
SPBP
-DNA complexes in vitro and acts as a positive cofactor in
SPBP
-mediated transactivation.
SPBP
harbors an internal zinc finger of the PHD/LAP type. This domain can form intra-chain protein-protein contacts in
SPBP
resulting in negative modulation of
SPBP
-RNF4 interaction.
...
PMID:Interaction between the transcription factor SPBP and the positive cofactor RNF4. An interplay between protein binding zinc fingers. 1084 25
SPBP
(
stromelysin-1 platelet-derived growth factor-responsive element binding protein
) was originally cloned from a cDNA expression library by virtue of its ability to bind to a platelet-derived growth factor-responsive element in the human
stromelysin
-1 promoter. A 937-amino acid-long protein was deduced from a 3995-nucleotide murine cDNA sequence. By analyses of both human and murine cDNAs, we now show that
SPBP
is twice as large as originally found. The human
SPBP
gene contains six exons and is located on chromosome 22q13.1-13.3. Two isoforms differing in their C termini are expressed due to alternative splicing. PCR analyses of multitissue cDNA panels showed that
SPBP
is expressed in most tissues except for ovary and prostate. Functional mapping revealed that
SPBP
is a nuclear, multidomain protein containing an N-terminal region with transactivating ability, a novel type of DNA-binding domain containing an AT hook motif, and a bipartite nuclear localization signal as well as a C-terminal zinc finger domain. This type of zinc finger domain is also found in the trithorax family of chromatin-based transcriptional regulator proteins. Using cotransfection experiments, we find that
SPBP
enhances the transcriptional activity of various transcription factors such as c-Jun, Ets1, Sp1, and Pax6. Hence,
SPBP
seems to act as a transcriptional coactivator.
...
PMID:The nuclear factor SPBP contains different functional domains and stimulates the activity of various transcriptional activators. 1099 66
Transcriptional regulation requires co-ordinated action of transcription factors, co-activator complexes and general transcription factors to access specific loci in the dense chromatin structure. In the present study we demonstrate that the transcriptional co-regulator
SPBP
[
stromelysin
-1 PDGF (platelet-derived growth factor)-responsive element binding protein] contains two independent chromatin-binding domains, the
SPBP
-(1551-1666) region and the C-terminal extended PHD [ePHD/ADD (extended plant homeodomain/ATRX-DNMT3-DNMT3L)] domain. The region 1551-1666 is a novel core nucleosome-interaction domain located adjacent to the AT-hook motif in the DNA-binding domain. This novel nucleosome-binding region is critically important for proper localization of
SPBP
in the cell nucleus. The ePHD/ADD domain associates with nucleosomes in a histone tail-dependent manner, and has significant impact on the dynamic interaction between
SPBP
and chromatin. Furthermore,
SPBP
and its homologue RAI1 (retinoic-acid-inducible protein 1), are strongly enriched on chromatin in interphase HeLa cells, and both proteins display low nuclear mobility. RAI1 contains a region with homology to the novel nucleosome-binding region
SPBP
-(1551-1666) and an ePHD/ADD domain with ability to bind nucleosomes. These results indicate that the transcriptional co-regulator
SPBP
and its homologue RAI1 implicated in Smith-Magenis syndrome and Potocki-Lupski syndrome both belong to the expanding family of chromatin-binding proteins containing several domains involved in specific chromatin interactions.
...
PMID:Identification of two independent nucleosome-binding domains in the transcriptional co-activator SPBP. 2208 70